PRINS RICHARD K 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
PRINS RICHARD K
Director
Transactions
- Gift
Common Stock
2024-12-09−410→ 30,061 total - Exercise/Conversion
Stock Option (right to buy)
2024-12-09−10,000→ 0 totalExercise: $19.52Exp: 2029-06-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2024-12-09$19.52/sh+10,000$195,200→ 40,471 total - Sale
Common Stock
2024-12-09$43.77/sh−10,000$437,702→ 30,471 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $43.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares subject to the option are fully vested and immediately exercisable.